Literature DB >> 23360582

Highly enantioselective synthesis of cyclopropylamine derivatives via Ru(II)-pheox-catalyzed direct asymmetric cyclopropanation of vinylcarbamates.

Soda Chanthamath1, Dao Thi Nguyen, Kazutaka Shibatomi, Seiji Iwasa.   

Abstract

The Ru(II)-Pheox-catalyzed asymmetric cyclopropanation of vinylcarbamates with diazoesters resulted in the corresponding cyclopropylamine derivatives in high yield and excellent diastereoselectivity (up to 96:4) and enantioselectivity (up to 99% ee).

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23360582     DOI： 10.1021/ol303404c

Source DB:  PubMed          Journal:  Org Lett        ISSN： 1523-7052            Impact factor:   6.005


  5 in total

1.  Catalytic Enantio- and Diastereoselective Cyclopropanation of 2-Azadienes for the Synthesis of Aminocyclopropanes Bearing Quaternary Carbon Stereogenic Centers.

Authors:  Xinxin Shao; Steven J Malcolmson
Journal:  Org Lett       Date:  2019-08-29       Impact factor: 6.005

2.  Diastereo- and Enantioselective CuH-Catalyzed Hydroamination of Strained Trisubstituted Alkenes.

Authors:  Sheng Feng; Hua Hao; Peng Liu; Stephen L Buchwald
Journal:  ACS Catal       Date:  2019-11-21       Impact factor: 13.084

Review 3.  The Curtius rearrangement: mechanistic insight and recent applications in natural product syntheses.

Authors:  Arun K Ghosh; Anindya Sarkar; Margherita Brindisi
Journal:  Org Biomol Chem       Date:  2018-02-26       Impact factor: 3.876

4.  Highly stereoselective spirocyclopropanation of various diazooxindoles with olefins catalyzed using Ru(ii)-complex.

Authors:  Masaya Tone; Yoko Nakagawa; Soda Chanthamath; Ikuhide Fujisawa; Naofumi Nakayama; Hitoshi Goto; Kazutaka Shibatomi; Seiji Iwasa
Journal:  RSC Adv       Date:  2018-11-28       Impact factor: 3.361

5.  Catalytic (3 + 2) annulation of donor-acceptor aminocyclopropane monoesters and indoles.

Authors:  Vincent Pirenne; Emma G L Robert; Jerome Waser
Journal:  Chem Sci       Date:  2021-05-05       Impact factor: 9.825
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.